The DOI matches its Crossref record; 71 of the 75 references it cites were found in a registry or an index.
Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors
Abstract
The anatomical distribution of serotonin-2 receptors in the human brain was studied by light microscopic autoradiography, using [3H]ketanserin as a ligand. The receptor densities were quantified by microdensitometry with the aid of a computer-assisted image-analysis system. A heterogeneous distribution of serotonin-2 receptor densities was found in the human brain. Very high concentrations were localized over layers III and V of several cortical areas, including the frontal, parietal, temporal and occipital lobes, the anterogenual cortex and the entorhinal area, as well as in the corpus mamillare of the hypothalamus. The claustrum, nucleus lateralis of the amygdala and some cortical layers also presented a high density of serotonin-2 receptors. Intermediate concentrations were found over the hippocampus, the caudatus, putamen and accumbens nuclei, and some nuclei of the amygdala, among other structures. Areas such as the thalamus, brain stem, cerebellum and spinal cord contained, in general, only low to very low densities of serotonin-2 receptors. A very high level of non-specific binding, which was not displaceable by any serotonin-2 compound, was found in some areas of the human brain, including the caudatus and putamen nuclei, the substantia nigra and the raphé nuclei. The distribution of serotonin-2 receptors in the human brain described herein is discussed in relation to the distribution of serotonergic innervation, the central effects which have been proposed to be serotonin-2-mediated, and the neuropathological characteristics of the diseases where a modification in the number of serotonin-2 receptors has been reported.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar pattern of 5-HT2A receptor expression has been shown in human post-mortem tissue using both autoradiography (211) and in situ hybridization (212).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [211]
Citations
Cites
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
A PROPOSED MECHANISM OF EMOTION
PAPEZ, J. W. (1937) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1937.02260220069003 · Cited by 3,563
Steinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,862
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Self-citationPeroutka, S. J., & Snyder, S. H. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13812-1 · Cited by 1,363
Neurobiology of the hippocampus
Rawlins, J. N. P. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90113-1 · Cited by 1,097
Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka, S. J., & Snyder, S. H. (1980) · Science · doi:10.1126/science.6251550 · Cited by 837
Pazos, Á., Cortés, R., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90857-1 · Cited by 824
Self-citationA new method for receptor autoradiography: [3H]Opioid receptors in rat brain
Young, W. S., & Kuhar, M. J. (1979) · Brain Research · doi:10.1016/0006-8993(79)90442-6 · Cited by 797
Research works printed but not linked: 4
- Blackshear, 1982, Serotonin receptors sensitivity after acute and chronic treatment with mianserin, J. Pharmac. exp. Ther., 221, 303
- Braak, 1980, Architectonic of the human telencephalic cortex, Vol. 4
- Harrison-Read, 1984, Noradrenergic and other strategies for devising new drug treatments of schizophrenia, Trends pharmac. Sci., 5, 139
- Leysen, 1982, [3H]Ketanserin (R 41 468), a selective3H-ligand for serotonin2 receptor binding sites, Molec. Pharmac., 21, 301
Cited by
Sorted by citations
Items 101–200 of 355
Smoking-associated changes in the serotonergic systems of discrete regions of human brain
Benwell, M. E. M., Balfour, D. J. K., & ANDERSON, J. M. (1990) · Psychopharmacology · doi:10.1007/bf02245746 · Cited by 90
Palacios, J. M., Pazos, Á., & Hoyer, D. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4545-5 · Cited by 92
Self-citationThe serotonin 5-HT1D receptor: A progress review
Waeber, C., Schoeffter, P., Hoyer, D., & Palacios, J. M. (1990) · Neurochemical Research · doi:10.1007/bf00973745 · Cited by 89
Self-citationDistribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex
Javoy-Agid, F., Scatton, B., Ruberg, M., L'Heureux, R., Cervera, P., Raisman‐Vozari, R., Maloteaux, J. M., Beck, H., & Agid, Y. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90055-9 · Cited by 88
Vermeire, S. T., Audenaert, K., Meester, R. H. D., Vandermeulen, E., Waelbers, T., Spiegeleer, B. M. J. D., Eersels, J. L. H., Dobbeleir, A. A., & Peremans, K. Y. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.06.006 · Cited by 90
Finger, E. C., Marsh, A. A., Buzas, B., Kamel, N., Rhodes, R., Vythilingham, M., Pine, D. S., Goldman, D., & Blair, J. R. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301182 · Cited by 86
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Stoliker, D., Egan, G. F., Friston, K. J., & Razi, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000508 · Cited by 96
Dyck, R. H., & Cynader, M. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04316.1993 · Cited by 84
Sheline, Y. I., Mintun, M. A., Barch, D. M., Wilkins, C. H., Snyder, A. Z., & Moerlein, S. M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300555 · Cited by 83
[3H]MDL100,907 labels 5-HT2A serotonin receptors selectively in primate brain
López‐Giménez, J. F., Vilaró, M. T., Palacios, J. M., & Mengod, G. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00102-6 · Cited by 80
Self-citationKinetic Analysis of the 5-HT 2A Ligand [ 11 C]MDL 100,907
Watabe, H., Channing, M. A., Der, M. G., Adams, H. R., Jagoda, E. M., Herscovitch, P., Eckelman, W. C., & Carson, R. E. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200006000-00002 · Cited by 80
Knockout Mice Reveal Opposite Roles for Serotonin 1A and 1B Receptors in Prepulse Inhibition
Dulawa, S. C. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00164-5 · Cited by 80
Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia
Busatto, G. F., & Kerwin, R. W. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100102 · Cited by 79
Li, Y.-Q., Takada, M., & Mizuno, N. (1993) · Neuroscience Research · doi:10.1016/0168-0102(93)90114-6 · Cited by 79
Application of cross-species PET imaging to assess neurotransmitter release in brain
Finnema, S. J., Scheinin, M., Shahid, M., Lehto, J., Borroni, E., Bang‐Andersen, B., Sallinen, J., Wong, E. H. F., Farde, L., Halldin, C., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3938-6 · Cited by 82
Expression of serotonin 5‐HT 2A receptors in the human cerebellum and alterations in schizophrenia
Eastwood, S. L., Burnet, P. W. J., Gittins, R., Baker, K., & Harrison, P. J. (2001) · Synapse · doi:10.1002/syn.1106 · Cited by 78
SEROTONERGIC MECHANISMS IN AMYOTROPHIC LATERAL SCLEROSIS
Sandyk, R. (2006) · International Journal of Neuroscience · doi:10.1080/00207450600754087 · Cited by 83
Antisense Inhibition of 5-Hydroxytryptamine2aReceptor Induces an Antidepressant-Like Effect in Mice
Sibille, E. L., Sarnyai, Z., Benjamin, D., Gál, J., Baker, H., & Tóth, M. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1056 · Cited by 78
Lidow, M. S., Goldman‐Rakic, P. S., Gallager, D. W., & Rakic, P. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902800104 · Cited by 77
Localization of pontine PGO wave generation sites and their anatomical projections in the rat
Datta, S., Siwek, D. F., Patterson, E. H., & Cipolloni, P. B. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199812)30:4 · Cited by 162
Yildirim, B. O., & Derksen, J. J. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.009 · Cited by 81
Rosier, A., Dupont, P. J., Peuskens, J., Bormans, G. M., Vandenberghe, R. R., Maes, M. H. J., de Groot, T., Schiepers, C. W., Verbruggen, A., & Mortelmans, L. (1996) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(96)02806-5 · Cited by 75
Neural Control of the Upper Airway: Respiratory and State‐Dependent Mechanisms
Kubin, L. K. (2016) · Comprehensive physiology · doi:10.1002/cphy.c160002 · Cited by 90
Cortical Serotonin Type-2 Receptor Density in Parents of Children with Autism Spectrum Disorders
Goldberg, J., Anderson, G. M., Zwaigenbaum, L., Hall, G. B., Nahmias, C., Thompson, A., & Szatmári, P. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0604-4 · Cited by 74
Cyto- and receptor architectonic mapping of the human brain
Palomero‐Gallagher, N., & Zilles, K. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00024-4 · Cited by 74
Serotonin 5-HT2 Receptors in Schizophrenic Patients Studied by Positron Emission Tomography
Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E., et al. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)80005-3 · Cited by 73
Domènech, T., Beleta, J., Fernández, A. G., Gristwood, R. W., Sánchez, F. C., Tolosa, E., & Palacios, J. M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90392-1 · Cited by 73
Self-citationBaeken, C., D’Haenen, H., Flamen, P., Mertens, J. J. R., Terriere, D., Chavatte, K., Boumon, R., & Bossuyt, A. M. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050339 · Cited by 72
Carlton, S. M., & Coggeshall, R. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00489-7 · Cited by 68
Gründer, G. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00044-4 · Cited by 68
5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine
Travis, M. J., Busatto, G. F., Pilowsky, L. S., Mulligan, R. S., Acton, P. D., Gacinovic, S., Mertens, J. J. R., Terriere, D., Costa, D. C., Ell, P. J., et al. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.3.236 · Cited by 68
Serotonin receptors in brain revisited
Palacios, J. M. (2015) · Brain Research · doi:10.1016/j.brainres.2015.12.042 · Cited by 67
Self-citationArchitecture, Connectivity, and Transmitter Receptors of Human Extrastriate Visual Cortex
Zilles, K., & Clarke, S. (1997) · Cerebral cortex · doi:10.1007/978-1-4757-9625-4_15 · Cited by 66
The cellular localization of 5-HT2A receptors in the spinal cord and spinal ganglia of the adult rat
Maeshima, T., Ito, R., Hamada, S., Senzaki, K., Hamaguchi‐Hamada, K., Shutoh, F., & Okado, N. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00360-6 · Cited by 66
Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches
Kantrowitz, J. T. (2020) · CNS Drugs · doi:10.1007/s40263-020-00752-2 · Cited by 68
Roth, B. L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.012 · Cited by 68
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 72
Distributions of transmitter receptors in the macaque cingulate cortex
Bozkurt, A., Zilles, K., Schleicher, A., Kamper, L., Sanz‐Arigita, E., Uylings, H. B. M., & Kötter, R. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.10.040 · Cited by 63
Lidow, M. S., Goldman, P. S., Gallager, D. W., Geschwind, D. H., & RAKIC, P. T. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90283-2 · Cited by 61
Pasqualetti, M., Nardi, I., Ladinsky, H., Marazziti, D., & Cassano, G. B. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00026-5 · Cited by 61
Molecular insights into psychedelic drug action
Slocum, S. T., DiBerto, J. F., & Roth, B. L. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15540 · Cited by 59
Vermeire, S. T., Audenaert, K., Dobbeleir, A. A., Meester, R. H. D., Vos, F. J. D., & Peremans, K. Y. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.055731 · Cited by 60
Ligands and tracers for PET studies of the 5-HT system—current status
Crouzel, C., Guillaume, M., Barré, L., Lemaire, C. F., & Pike, V. W. (1992) · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · doi:10.1016/0883-2897(92)90172-u · Cited by 60
Erritzøe, D., Holst, K. K., Frøkjær, V. G., Licht, C. L., Kalbitzer, J., Nielsen, F. Å., Svarer, C., Madsen, J., & Knudsen, G. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2852-09.2010 · Cited by 59
Radiosynthesis and Characterization of 11C-GSK215083 as a PET Radioligand for the 5-HT6 Receptor
Parker, C. A., Gunn, R. N., Rabiner, E. A., Slifstein, M., Comley, R. A., Salinas, C. A., Johnson, C. N., Jakobsen, S., Houle, S., Laruelle, M. A., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.093419 · Cited by 59
Roseman, L., Sereno, M. I., Leech, R., Kaelen, M., Orbán, C., McGonigle, J., Feilding, A., Nutt, D., & Carhart-Harris, R. L. (2016) · Human Brain Mapping · doi:10.1002/hbm.23224 · Cited by 59
Carrive, P., & Morgan, M. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374236-0.10010-0 · Cited by 59
Price, J. C., Lopresti, B. J., MELTZER, C. C., Smith, G. S., Mason, N. S., Huang, Y. H., Holt, D. P., Gunn, R. N., & Mathis, C. A. (2001) · Synapse · doi:10.1002/syn.1055 · Cited by 59
Aqil, M., & Roseman, L. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109300 · Cited by 63
Koskinen, T., & Sirviö, J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00425-1 · Cited by 56
Distribution of 5-HT Receptors in the Central Nervous System
Mengod, G., Cortés, R., Vilaró, M. T., & Hoyer, D. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70074-6 · Cited by 56
Laporte, A., Doyen, C., Nevo, I., Chauveau, J., Hauw, J., & Hamon, M. (1996) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(96)00130-5 · Cited by 56
Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration
Ikemoto, K., Nishimura, A., Okado, N., Mikuni, M., Nishi, K., & Nagatsu, I. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02237-4 · Cited by 56
Bozzini, V. (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000297 · Cited by 53
Slifstein, M., Kegeles, L. S., Gonzales, R., Frankle, W. G., Xu, X., Laruelle, M. A., & Abi‐Dargham, A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600468 · Cited by 51
Burt, J. B., Preller, K. H., Demirtaş, M., Ji, J. L., Krystal, J. H., Vollenweider, F. X., Anticevic, A., & Murray, J. D. (2021) · eLife · doi:10.7554/elife.69320 · Cited by 48
Efferent projections of the anterior perirhinal cortex in the rat
McIntyre, D., Kelly, M. E., & Staines, W. A. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960527)369:2 · Cited by 153
Serotonin in antipsychotic drugs action
Amato, D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.025 · Cited by 52
Brain 5-HT2A receptors in MPTP monkeys and levodopa-induced dyskinesias
Riahi, G., Morissette, M., Parent, M., & Paolo, T. D. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07675.x · Cited by 51
Wettstein, J. G., Host, M., & Hitchcock, J. M. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00014-7 · Cited by 52
Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT6 receptor antagonist
Dawson, L. A., Nguyen, H. Q., & Li, P. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00967-x · Cited by 52
5HT2C CYS23/SER23 polymorphism is not associated with obsessive–compulsive disorder
Cavallini, M. C., Bella, D. D., Pasquale, L., Henin, M., & Bellodi, L. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(97)00151-0 · Cited by 52
Receptor-driven, multimodal mapping of the human amygdala
Kedo, O., Zilles, K., Palomero‐Gallagher, N., Schleicher, A., Mohlberg, H., Bludau, S., & Amunts, K. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1577-x · Cited by 52
Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements
Naidu, P. S., & Kulkarni, S. K. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01284-5 · Cited by 51
Cartography of 5-HT1Aand 5-HT2AReceptor Subtypes in Prefrontal Cortex and Its Projections
Mengod, G., Palacios, J. M., & Cortés, R. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00023 · Cited by 52
Self-citation5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA
Huot, P., Johnston, T. H., Winkelmolen, L., Fox, S. H., & Brotchie, J. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.035 · Cited by 50
Peremans, K. Y., Audenaert, K., Hoybergs, Y. M. J. J., Otte, A., Goethals, I., Gielen, I., Blankaert, P., Vervaet, M., Heeringen, C. V., & Dierckx, R. A. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1772-5 · Cited by 50
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brain
Nordström, A., Månsson, M., Jovanovic, H., Karlsson, P., Halldin, C., Farde, L., Vanover, K. E., Hacksell, U., Brann, M. R., Davis, R. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007869 · Cited by 49
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Canal, C. E. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_107 · Cited by 50
Differential acute effects of fluoxetine on frontal and auditory cortex networks in vitro
Xia, Y., Gopal, K. V., & Gross, G. W. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02367-9 · Cited by 48
Moresco, R. M., Colombo, C., Fazio, F., Bonfanti, A., Lucignani, G., Messa, C., Gobbo, C., Galli, L., Sole, A. D., Lucca, A., et al. (2000) · NeuroImage · doi:10.1006/nimg.2000.0619 · Cited by 48
Strome, E. M., Clark, C. M., Zis, A. P., & Doudet, D. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.025 · Cited by 47
Pimavanserin for the treatment of Parkinson's disease psychosis
Friedman, J. H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.819345 · Cited by 48
Pinborg, L., Adams, K. H., Yndgaard, S., Hasselbalch, S., Holm, S., Kristiansen, H., Paulson, O., & Knudsen, G. (2004) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1097/01.wcb.0000126233.08565.e7 · Cited by 50
Guimarães, A. P. M., Zeni, C., Polanczyk, G. V., Genro, J. P., Roman, T., Rohde, L. A., & Hutz, M. H. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30400 · Cited by 44
Andrée, B., Nyberg, S., Ito, H., Ginovart, N., Brunner, F., Jaquet, F., Halldin, C., & Farde, L. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199808000-00012 · Cited by 45
Serotonin2A receptors are reduced in the planum temporale from subjects with schizophrenia
Pralong, D., Tomaskovic‐Crook, E., Opeskin, K., Copolov, D., & Dean, B. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00150-4 · Cited by 42
Cohen, H. (2005) · Depression and Anxiety · doi:10.1002/da.20087 · Cited by 40
Busatto, G. F., Pilowsky, L. S., Costa, D. C., Mertehs, J., Terriere, D., Ell, P. J., Mulligan, R. S., Travis, M. J., Leysen, J. E., Lui, D., et al. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf02439542 · Cited by 40
Monoaminergic Innervation of Cingulate Cortex
Crino, P. B., Morrison, J. H., & Hof, P. R. (1993) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6704-6_10 · Cited by 39
Waeber, C., & Palacios, J. M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90133-3 · Cited by 39
Self-citationDecreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia
Hurlemann, R., Boy, C., Meyer, P. T., Scherk, H., Wagner, M., Herzog, H. R., Coenen, H. H., Vogeley, K. T., Falkai, P., Zilles, K., et al. (2005) · Anatomy and Embryology · doi:10.1007/s00429-005-0036-2 · Cited by 39
Autoradiographic Studies of Serotonin Receptors
Palacios, J. M., & Dietl, M. M. (1988) · Humana Press eBooks · doi:10.1007/978-1-4612-4560-5_4 · Cited by 39
Self-citationAnji, A., Kumari, M., Sullivan, N. R., Bryan, G. S., & Hensler, J. G. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00026-5 · Cited by 38
Cross, A. J., Slater, P., Perry, E. K., & Perry, R. H. (1988) · Neurochemistry International · doi:10.1016/0197-0186(88)90107-6 · Cited by 37
Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice
Dougherty, J. P., & Aloyo, V. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2207-6 · Cited by 39
Dourron, H. M., Strauss, C. K., & Hendricks, P. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000514 · Cited by 35
Barone, P. R., Jordan, D., Atger, F., Kopp, N., & Fillion, G. (1994) · Brain Research · doi:10.1016/0006-8993(94)90636-x · Cited by 36
Transmitter Receptor Distribution in the Human Brain
Palomero‐Gallagher, N., Amunts, K., & Zilles, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00221-9 · Cited by 34
Quednow, B. B., Treyer, V., Hasler, F., Doerig, N., Wyss, M. T., Burger, C., Rentsch, K., Westera, G., Schubiger, P. A., Buck, A., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.045 · Cited by 35
López‐Giménez, J. F., Mengod, G., Palacios, J. M., & Vilaró, M. T. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00827.x · Cited by 35
Self-citationNociceptive integration: Does it have a peripheral component?
Carlton, S. M., & Coggeshall, R. E. (1998) · Pain Forum · doi:10.1016/s1082-3174(98)80031-7 · Cited by 35
Quantitation of 5HT2A receptor mRNA in human postmortem brain using competitive RT-PCR
Dwivedi, Y. K., & Pandey, G. N. (1998) · Neuroreport · doi:10.1097/00001756-199812010-00001 · Cited by 35
Chemical Neuroanatomy of 5-HT Receptor Subtypes in the Mammalian Brain
Mengod, G., Vilaró, M. T., Cortés, R., López-Giménez, J. F., Raurich, A., & Palacios, J. M. (2006) · The Receptors · doi:10.1007/978-1-59745-080-5_10 · Cited by 33
Self-citationRiga, M. S., Bortolozzi, A. A., Campa, L., Artigas, F., & Celada, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.016 · Cited by 33
Hagberg, G. E., Gefvert, O., Bergström, M., Wieselgren, I., Lindström, L., Wiesel, F., & Långström, B. (1998) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(98)00020-1 · Cited by 33
The Effects of Psychedelics on Neuronal Physiology
Hatzipantelis, C. J., & Olson, D. E. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-020923 · Cited by 39
Gervais, J., Soghomonian, J., Richard, D., & Rouillard, C. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00688-5 · Cited by 32
MacGillivray, L., Reynolds, K. B., Sickand, M., Rosebush, P. I., & Mazurek, M. F. (2011) · Synapse · doi:10.1002/syn.20954 · Cited by 32
PET radioligands for the dopamine D1-receptor: Application in psychiatric disorders
Červenka, S. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.03.007 · Cited by 30
Metadata
- Authors
- Pazos, A., Probst, A., & Palacios, J. M.
- Affiliations
- University of Basel (CH)
- Sandoz Group AG (Switzerland) (CH)
- Corresponding author
- Palacios, J.M.
- ORCID
- Palacios, J.M.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1987-04
- Volume
- 21
- Issue
- 1
- Pages
- 123-139
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W4319425390
- Cited by
- 355
- References
- 75
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 9 · 2017: 14 · 2016: 6 · 2015: 9 · 2014: 10 · 2013: 6 · 2012: 4
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- serotonin 2 receptor, human brain, receptor distribution, entorhinal area, hippocampus, basal ganglia, substantia nigra, raphe nuclei, non-specific binding, serotonergic innervation, neurodegenerative diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review